Imunon, Inc. Stock Issued During Period, Shares, New Issues
Imunon, Inc. (IMNN) had Stock Issued During Period, Shares, New Issues of 2.12 million shares as of 2025-07-22, per its 10-Q filed 2026-05-12.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-05-12
- 2025-07-22: Stock Issued During Period, Shares, New Issues 2.12M shares.
- 2025-06-02: Stock Issued During Period, Shares, New Issues 2.10M shares.
- 2020-09-30: Stock Issued During Period, Shares, New Issues 1 month 2.00M shares.
- 2014-01-15: Stock Issued During Period, Shares, New Issues 0 month 3.60M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues 0 month as first filed | Stock Issued During Period, Shares, New Issues 1 month | Stock Issued During Period, Shares, New Issues 1 month as first filed |
|---|---|---|---|---|---|
| 2025-07-22 | 2.12M shares 10-Q · filed 2026-05-12 | ||||
| 2025-06-02 | 2.10M shares 10-Q · filed 2026-05-12 | ||||
| 2020-09-30 | 2.00M shares 10-Q · filed 2020-11-16 | ||||
| 2014-01-15 | 3.60M shares 10-Q · filed 2014-08-07 | ||||
| 2013-05-30 | 1.39M shares 10-Q · filed 2014-08-07 | 6.26M shares 10-Q · filed 2013-08-08 | |||
| 2013-02-25 | 1.20M shares 10-Q · filed 2014-08-07 | 5.38M shares 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |